BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7479231)

  • 21. Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.
    Alli C; Lombardo M; Zanni D; Agrati AM; Cassani M; Granata S
    Am J Hypertens; 1996 Nov; 9(11):1068-76. PubMed ID: 8931831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study.
    Midtvedt K; Ihlen H; Hartmann A; Bryde P; Bjerkely BL; Foss A; Fauchald P; Holdaas H
    Transplantation; 2001 Jul; 72(1):107-11. PubMed ID: 11468543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.
    Mogensen CE; Neldam S; Tikkanen I; Oren S; Viskoper R; Watts RW; Cooper ME
    BMJ; 2000 Dec; 321(7274):1440-4. PubMed ID: 11110735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lisinopril in essential hypertension: a six month comparative study with nifedipine.
    Richardson PJ; Meany B; Breckenridge AM; Grimmer SF; Johnston GD; Kondowe G
    J Hum Hypertens; 1987 Dec; 1(3):175-9. PubMed ID: 2852252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients.
    Tuominen JA; Ebeling P; Koivisto VA
    Diabetes Care; 1998 Aug; 21(8):1345-8. PubMed ID: 9702445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary kallikrein excretion and blood pressure response to angiotensin converting enzyme inhibitors and calcium antagonists in hypertensive patients.
    Dessì-Fulgheri P; Espinosa E; Zingaretti O; Guazzarotti F; Sarzani R; Pupita G; Sturbini S; Catalini R; Rappelli A
    J Hypertens; 1993 Jul; 11(7):725-30. PubMed ID: 8228191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.
    Sengul AM; Altuntas Y; Kürklü A; Aydin L
    Diabetes Res Clin Pract; 2006 Feb; 71(2):210-9. PubMed ID: 16112244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients.
    Asberg A; Midtvedt K; Vassbotn T; Hartmann A
    Nephrol Dial Transplant; 2001 Jul; 16(7):1465-70. PubMed ID: 11427642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the antihypertensive effect of lisinopril compared with nifedipine in patients with mild to severe essential hypertension.
    Eber B; Brussee H; Rotman B; Kramer R; Klein W
    Angiology; 1992 Jun; 43(6):482-9. PubMed ID: 1317687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy.
    Holdaas H; Hartmann A; Lien MG; Nilsen L; Jervell J; Fauchald P; Endresen L; Djøseland O; Berg KJ
    J Intern Med; 1991 Feb; 229(2):163-70. PubMed ID: 1847721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Within-patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine.
    Attwood S; Bird R; Burch K; Casadei B; Coats A; Conway J; Dawes M; Ebbs D; Farmer A; Robinson J
    J Hypertens; 1994 Sep; 12(9):1053-60. PubMed ID: 7852749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect.
    Watanabe Y; Takasugi E; Shitakura K; Okajima K; Hota N; Kubo Y; Nunoda S; Otsuka K
    Clin Exp Hypertens; 2011; 33(4):246-54. PubMed ID: 21699451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG; Kramer HJ
    J Hum Hypertens; 1994 Oct; 8(10):777-80. PubMed ID: 7837215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril.
    Midtvedt K; Hartmann A; Foss A; Fauchald P; Nordal KP; Rootwelt K; Holdaas H
    Transplantation; 2001 Dec; 72(11):1787-92. PubMed ID: 11740389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ; Ramsay LE; Hettiarachchi J
    Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of lisinopril and nifedipine on parotid function: two case reports.
    Streckfus CF; Welsh S; Jenkins P; Brown R; Miller V
    MSDA J; 1992; 35(4):11-4. PubMed ID: 9552628
    [No Abstract]   [Full Text] [Related]  

  • 39. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
    Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
    Waeber B; Weidmann P; Wohler D; Le Bloch Y
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.